We're close to the world's first-ever broad-spectrum antiviral. In a breakthrough, researchers at the City University of New York have identified a promising path to the development of an antiviral that could be used to fight a wide range of deadly viruses, including future pandemic threats.

Their efficacy was confirmed against LIVE viruses including Ebola, Marburg, Nipah, Hendra, SARS-CoV, SARS-CoV-2 (COVID-19), AND Middle East Respiratory Syndrome (MERS).

The study has been published in Science Advances. YES, it is PEER-REVIEWED.
• www.science.org/doi/10.1126/...

🧪🧵⬇️

LET’S FUCKIN GOOOOO

i think ppl rly appreciate seeing someone be bold with their outfits
feels like they wish they could be that bold too

🥹🥹🥹 you’re very kind, thank you 🥰

thank you 🥹 it’s kohl very painstakingly applied